Trial Condition(s):

Bacterial Infection

Magnetic resonance imaging (MRI) scans to investigate any arthropathic effects of a 14 day course of ciprofloxacin bd oral tablets on the joints of children with Pseudomonas aeruginosa exacerbations of cystic fibrosis

Bayer Identifier:

Trial_1427

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

May1995

July1996

Phase

Could I receive a placebo?

Products

Cipro (Ciprofloxacin hydrochloride, BAYO9867)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Bacterial Infection

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

5 Years

14 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information